Missouri 2025 Regular Session

Missouri Senate Bill SB641

Introduced
1/28/25  

Caption

Creates provisions regulating intoxicating cannabinoids

Impact

The bill mandates that all entities engaged in the sale of intoxicating cannabinoids register annually with the department of health and senior services. Those currently selling these products prior to the registration requirement must complete their registration within 45 days after the bill's provisions take effect on August 28, 2025. This requirement aims to enhance regulatory oversight and promote consumer safety in the cannabinoid market while allowing for continued sales during the transition to compliance.

Summary

Senate Bill 641 establishes new regulations surrounding the sale and distribution of intoxicating cannabinoids in the state of Missouri. The bill defines 'intoxicating cannabinoids' as any cannabinoid that produces an intoxicating effect when ingested, regardless of the method of its creation. This includes synthetically derived, semi-synthetic, or plant-based cannabinoids, excluding cannabidiol (CBD). The legislation is an attempt to ensure that sales of such products are handled safely and legally, reflecting a significant shift in the state’s approach to cannabinoid regulation.

Contention

Notably, the bill stipulates that sales of intoxicating cannabinoids are restricted to individuals aged 21 and older, necessitating robust age verification systems to prevent underage access. These regulations may generate debate regarding their sufficiency in protecting public health, especially concerning minors and potential abuse of such substances. Opponents may argue that stricter regulatory frameworks could stifle the industry, while proponents assert that without such oversight, public health risks could be heightened.

Implementation

The legislation requires the department to create rules that include safety testing, packaging standards to prevent access by minors, and recall procedures for dangerous products. This comprehensive regulatory framework signifies a proactive stance by the state to manage potential health risks associated with intoxicating cannabinoids while balancing the interests of those in the industry.

Companion Bills

No companion bills found.

Similar Bills

AZ SB1453

Hemp-derived impairing cannabinoids; regulation

SC S0137

Hemp-Derived Cannabinoids

UT HB0054

Cannabinoid Amendments

SC H3601

Hemp Derived Canabis

NJ A1890

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

AL SB255

Cannabinoid products from hemp; sale regulated by Revenue Department, licensure required; tax imposed

MN HF1615

Cannabis policy bill.

MN SF2370

Omnibus Cannabis Policy Bill